Policies to promote affordability and access across the life cycle of costly new drugs

Krista Kruja; Jorge Mestre‐Ferrandiz; Michael M. Hopkins; Bettina Ryll; Zoltán Kaló; Suerie Moon

doi:10.1136/bmj-2025-086516

November 11, 2025BMJOpen Access

Policies to promote affordability and access across the life cycle of costly new drugs

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to find ways to make new, expensive drugs more affordable and accessible for everyone.
Discussion of strategic collaborations among countries and sectors
Focus on policies that prioritize equity
Emphasis on the entire medicine life cycle
Presenting potential solutions for increasing drug affordability
Highlighting the importance of global collaboration for equitable access
Arguing for a systematic approach to policy development that includes diverse stakeholders

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Strategic collaboration highlights policies that enhance drug affordability and access globally, indicating equity efforts are essential.

Abstract

Strategic collaboration among countries and sectors on policies that prioritise equity throughout the full medicine life cycle could make innovative therapies more affordable and accessible globally, argue Krista Kruja and colleagues

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kruja et al. (2025) studied this question.

synapsesocial.com/papers/6a61a2527c867c6ae43f7348 https://doi.org/10.1136/bmj-2025-086516

View Full Paper

Ask AI

Bookmark

Share

Policies to promote affordability and access across the life cycle of costly new drugs

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Policies to promote affordability and access across the life cycle of costly new drugs

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading